Drug-drug interactions by azole antifungals: Beyond a dogma of CYP3A4 enzyme activity inhibition
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15310%2F11%3A33119053" target="_blank" >RIV/61989592:15310/11:33119053 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1016/j.toxlet.2011.01.027" target="_blank" >http://dx.doi.org/10.1016/j.toxlet.2011.01.027</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.toxlet.2011.01.027" target="_blank" >10.1016/j.toxlet.2011.01.027</a>
Alternative languages
Result language
angličtina
Original language name
Drug-drug interactions by azole antifungals: Beyond a dogma of CYP3A4 enzyme activity inhibition
Original language description
Azoles antifungals are widespread used drugs for various medicinal indications. These drugs are well known for their numerous drug-drug interactions, which are believed to occur via inhibition of CYP3A4 enzymatic activity and consequently altering pharmacokinetic of co-administered drugs. In the current communication a complex view on the molecular interactions between azoles antimycotics and CYP3A4 is presented. Beside inhibition of CYP3A4 catalytic activity, azoles influence transcriptional activity of pregnane X receptor (PXR) and consequently expression of drug-metabolizing enzymes, including CYP3A4. Interactions between azoles and PXR occur by multiple mechanisms, including modulation of ligand-dependent activation of PXR (agonism, antagonism) oraffecting recruitment of PXR co-activators SRC-1 (steroid receptorco-activator 1)and HNF4 alpha (hepatocyte nuclear factor 4 alpha). Miconazole and ketoconazole are antagonists of glucocorticoid receptor (GR), therefore these drugs inhibi
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FR - Pharmacology and apothecary chemistry
OECD FORD branch
—
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2011
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Toxicology Letters
ISSN
0378-4274
e-ISSN
—
Volume of the periodical
202
Issue of the periodical within the volume
2
Country of publishing house
IE - IRELAND
Number of pages
4
Pages from-to
129-132
UT code for WoS article
000289708000007
EID of the result in the Scopus database
—